//
Matthew J. Wieduwilt
Leland Metheny III
Mei-Jie Zhang
Hai-Lin Wang
Noel Estrada-Merly
Marcos de Lima
Mark Litzow
Partow Kebriaei
Chris S. Hourigan
Daniel J. Weisdorf
Wael Saber
Moores Cancer Center, University of California, San Diego, La Jolla, CA
Adult Hematologic Malignancies & Stem Cell Transplant Program, University Hospitals, Seidman Cancer Center, Cleveland, OH
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
Case Western Reserve University, Cleveland, OH
Division of Medical Oncology, Mayo Clinic, Rochester, MN
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Laboratory of Myeloid Malignancies, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD
Department of Pediatrics, Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
United States
N/A
Autoimmune (AI)
Acute lymphoblastic leukemia
Graft-versus-host disease
Breakpoint Cluster Region
Cyclophosphamide
Cyclophosphamide Injection
N/A
Multinational
NA
N/A
N/A
N/A